News

« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 10 of 39

Vice President Biden ties Providence to Cancer Moonshot

June 30, 2016

More than 150 people took part as Providence Cancer Center participated in Vice President Biden’s Cancer Moonshot Summit. The goal is to make a decade worth of advances toward a cure in five years, from increasing access to treatment and improving care to freeing trapped data and unleashing new breakthroughs.

Major Providence supporter Earle M. Chiles passes away

June 24, 2016

We mourn the passing of Earle M. Chiles, 83, a long-time champion and supporter of providing exceptional health care for Providence patients in Oregon.

Nearly One Million Dollars Raised for Immunotherapy Research at Providence

May 31, 2016

Excited by the promise and power of immunotherapy research, Providence Cancer Center supporters raised nearly $1 million in the month of May, with most of that coming at the 2016 Creating Hope through Innovation Dinner May 25.

Providence cancer physician and scientist named as one of nation's 15 most promising young researchers

April 14, 2016

Just a year into her career as a Providence Cancer Center radiation oncologist and scientist, Kristina Young, M.D., Ph.D., has been recognized as...

Providence researchers find immunotherapy treatment synergizes with targeted radiation eliminating tumors, destroying errant cancer cells

January 13, 2016

Providence researchers have identified an immunotherapy approach that synergizes with radiation so well it not only eliminated the tumor in most preclinical models with pancreatic cancer, it found and destroyed distant, cancer cells – which could have grown into lethal metastatic tumors.

Immunoregulartory Protein (Cancer)

January 12, 2016

Providence Cancer Center researchers might have identified how to determine if a patient with advanced melanoma will likely respond to a certain immunotherapy treatment.

Breakthrough lung cancer drug helps clinical trial patient

March 06, 2015

A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.

OX40 work has reached a new milestone

October 16, 2014
The first patients were treated with the human version in clinical trials, including at Providence Cancer Center.

Dr. Urba honored as ‘cancer warrior’

October 07, 2014
The Oregon Historical Society recognized Walter J. Urba, M.D., Ph.D., as a 2014 Oregon History Maker at its Oct. 5 awards dinner, referencing him as a “cancer warrior.”

Multimillion dollar grant improves access to cancer care and clinical trials

August 07, 2014

Cancer patients in Oregon, Washington and three other Western states will receive improved access to care and clinical trials as a result of a new $6.6 million grant from the National Cancer Institute’s Community Oncology Research Program, or NCORP. 

« Previous 1234 Next »
Viewing Page 1 of 4 | Showing Results 1 - 10 of 39